Edition:
India

Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

101.44USD
12:47am IST
Change (% chg)

$0.65 (+0.64%)
Prev Close
$100.79
Open
$100.31
Day's High
$102.57
Day's Low
$98.97
Volume
133,491
Avg. Vol
290,575
52-wk High
$112.83
52-wk Low
$90.21

Select another date:

Wed, Apr 4 2018

BRIEF-Quest Diagnostics Says CEO Rusckowski's 2017 Total Compensation Was $10.35 Mln Vs $10.25 Mln In 2016 ‍​

* QUEST DIAGNOSTICS INC SAYS CEO STEPHEN H. RUSCKOWSKI'S 2017 TOTAL COMPENSATION WAS $10.35 MILLION VERSUS $10.25 MILLION IN 2016 – SEC FILING ‍​ Source text: (https://bit.ly/2uKsWVj) Further company coverage:

BRIEF-Quest, Humana, Multiplan, Optum, UnitedHealthcare Launch Blockchain Program

* Quest - CO, HUMANA, MULTIPLAN, UNITEDHEALTH GROUP'S OPTUM, UNITEDHEALTHCARE LAUNCH BLOCKCHAIN PROGRAM TO IMPROVE DATA QUALITY AMONG OTHERS Source text for Eikon: Further company coverage:

BRIEF-Genomic Vision Extends Its Collaboration With Quest Diagnostics​

* ‍GENOMIC VISION EXTENDS ITS COLLABORATION WITH QUEST DIAGNOSTICS IN SPINAL MUSCULAR ATROPHY (SMA)​

BRIEF-Quest Diagnostics Reports Q4 Adjusted Earnings Per Share $1.40

* QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2018; INCREASES DIVIDEND 11% TO $0.50 PER QUARTER

BRIEF-Fresenius Medical Care Closes Divestment Of Shiel Medical Laboratory To Quest Diagnostics

* DGAP-NEWS: FRESENIUS MEDICAL CARE CLOSES DIVESTMENT OF SHIEL MEDICAL LABORATORY TO QUEST DIAGNOSTICS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Quest Diagnostics provides update on impact of 2018 Medicare payment rates

* Quest Diagnostics provides update on impact of final 2018 Medicare payment rates for clinical laboratory tests

BRIEF-FDA approves Clinical Genomics, Quest Diagnostics Insure One

* Clinical Genomics and Quest Diagnostics announce FDA 510(k) clearance of Insure® One™

BRIEF-Quest Diagnostics acquires certain assets of California Laboratory Associates

* Quest Diagnostics acquires California Laboratory Associates

BRIEF-Advantage Capital Portfolio company Cleveland Heartlab acquired by Quest Diagnostics

* Advantage Capital Portfolio company Cleveland Heartlab, Inc acquired by Quest Diagnostics

Select another date: